Ensuring Integrity in Industry-Sponsored Research Primum Non Nocere, Revisited

被引：35

作者：

DeAngelis, Catherine D.

Fontanarosa, Phil B.

机构：

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2010年 / 303卷 / 12期

关键词：

CONFLICTS-OF-INTEREST; ROFECOXIB LITIGATION; ROSIGLITAZONE; DOCUMENTS; TRIALS;

D O I：

10.1001/jama.2010.337

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1196 / 1198

页数：3

共 16 条

[1]

[Anonymous], JAMA INSTR AUTH

[2] Expression of concern: Bombardier et al., "Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis," N Engl J Med 2000;343:1520-8 [J].

Curfman, GD ;

Morrissey, S ;

Drazen, JM .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (26) :2813-2814

[3] Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors [J].

De Angelis, CD ;

Drazen, JM ;

Frizelle, FA ;

Haug, C ;

Hoey, J ;

Horton, R ;

Kotzin, S ;

Laine, C ;

Marusic, A ;

Overbeke, AJPM ;

Schroeder, TV ;

Sox, HC ;

Van der Weyden, MB .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (23) :2927-2929

[4] Impugning the integrity of medical science - The adverse effects of industry influence [J].

DeAngelis, Catherine D. ;

Fontanarosa, Phil B. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (15) :1833-1835

[5] Reporting financial conflicts of interest and relationships between investigators and research sponsors [J].

DeAngelis, CD ;

Fontanarosa, PB ;

Flanagin, A .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01) :89-91

[6] Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies [J].

Fontanarosa, PB ;

Flanagin, A ;

DeAngelis, CD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (01) :110-111

[7]

HARRIS G, 2010, NY TIMES 0220

[8]

HARRIS GA, 2010, NY TIMES 0222

[9] Rosiglitazone evaluated for cardiovascular outcomes - An interim analysis [J].

Home, Philip D. ;

Pocock, Stuart J. ;

Beck-Nielsen, Henning ;

Gomis, Ramon ;

Hanefeld, Markolf ;

Jones, Nigel P. ;

Komajda, Michel ;

McMurray, John J. V. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (01) :28-38

[10] Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial [J].

Home, Philip D. ;

Pocock, Stuart J. ;

Beck-Nielsen, Henning ;

Curtis, Paula S. ;

Gomis, Ramon ;

Hanefeld, Markolf ;

Jones, Nigel P. ;

Komajda, Michel ;

McMurray, John J. V. .

LANCET, 2009, 373 (9681) :2125-2135

← 1 2 →